In the latest trading session,, 0.48 million Pulmonx Corp (NASDAQ:LUNG) shares changed hands as the company’s beta touched 0.68. With the company’s most recent per share price at $7.72 changed hands at -$0.29 or -3.62% at last look, the market valuation stands at $299.69M. LUNG’s current price is a discount, trading about -92.23% off its 52-week high of $14.84. The share price had its 52-week low at $7.11, which suggests the last value was 7.9% up since then. When we look at Pulmonx Corp’s average trading volume, we note the 3-month average coming to 515.65K.
Pulmonx Corp (NASDAQ:LUNG) trade information
Instantly LUNG was in red as seen in intraday trades today. With action -12.07%, the performance over the past five days has been red. The drop to weekly highs of 9.14 subtracted -3.62% to the stock’s daily price. The company’s shares are showing year-to-date downside of -39.45%, with the 5-day performance at -12.07% in the red. However, in the 30-day time frame, Pulmonx Corp (NASDAQ:LUNG) is 2.93% up.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pulmonx Corp (LUNG) estimates and forecasts
Data shows that the Pulmonx Corp share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -30.39% over the past 6 months, a -2.50% in annual growth rate that is considerably lower than the industry average of 16.90%. Year-over-year growth is forecast to reach 20.70% up from the last financial year.
Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of 20.2M. 5 analysts are of the opinion that Pulmonx Corp’s revenue for the current quarter will be 20.55M. The company’s revenue for the corresponding quarters a year ago was 17.19M and 16.39M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 17.50%. The estimates for the next quarter sales put growth at 25.40%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -25.16%. The 2024 estimates are for Pulmonx Corp earnings to decrease by -6.94%, but the outlook for the next 5-year period is at 23.60% per year.
LUNG Dividends
Pulmonx Corp is expected to release its next quarterly earnings report in June.
